Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.
Regelgeving en recht · 2-10-20151 min lezen
Prospective Grant of Exclusive License: Development of a ME-TARP Based Immunotherapy
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
This is notice, in accordance with 35 U.S.C. 209 and 37 CFR 404.7, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to PDS Biotechnology Corporation ("PDS") located in New Brunswick, New Jersey, USA:
Oorspronkelijke brontaal: Federal Register — All DocumentsOrigineel bericht openen →